Inhibrx Biosciences Files to Sell 2.45M Shares of Common Stock for Holders

Seeking AlphaJun 11 17:23 ET

Inhibrx Biosciences(INBX.US) Director Buys US$997.02K in Common Stock

$Inhibrx Biosciences(INBX.US)$ Director Kayyem Jon Faiz purchased 57,549 shares of common stock on Jun 5, 2024 at an average price of $17.32 for a total value of $997.02K.Source: Announcement What is

moomoo NewsJun 7 18:45 ET

Express News | Inhibrx Biosciences 13G Filing Shows Viking Global Investors LP Reported A 12.3% Stake In The Co As Of May 29, 2024

BenzingaJun 7 16:29 ET

Express News | Viking Global Investors LP Reports 12.3% Passive Stake in Inhibrx Biosciences, Inc. as of May 29, 2024- SEC Filing

ReutersJun 7 16:27 ET

Top 4 Health Care Stocks That Are Preparing To Pump This Month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u

BenzingaJun 5 07:46 ET

Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing

Jon Faiz Kayyem, Director, on May 31, 2024, executed a purchase for 286,786 shares in Inhibrx Biosciences (INBX) for $4,927,580. Following the Form 4 filing with the SEC, Kayyem has control over a tot

MT NewswiresJun 4 17:31 ET